Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 22.


Hardwick, Marc, Nolan, Luke, Nicoll, James, Jogai, Sanjay, Arriola, Edurne, Joseph-Pietras, Debora, Ottensmeier, Christian ORCID: 0000-0003-3619-1657 and Galea, Ian
(2021) CD8 T cell-mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer. JOURNAL OF THE NEUROLOGICAL SCIENCES, 429 (2). pp. 30-31.


Modi, Sachin, Gibson, Tom, Vigneswaran, Ganesh, Patel, Shian, Wheater, Matthew, Karydis, Ioannis, Gupta, Sanjay, Takhar, Arjun, Pearce, Neil, Ottensmeier, Christian ORCID: 0000-0003-3619-1657
et al (show 1 more authors) (2022) Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma. MELANOMA RESEARCH, 32 (2). pp. 103-111.


Zhu, Yanfang Peipei ORCID: 0000-0001-6908-0860, Eggert, Tobias, Araujo, Daniel, Vijayanand, Pandurangan, Ottensmeier, Christian ORCID: 0000-0003-3619-1657 and Hedrick, Catherine
(2019) CyTOF reveals phenotypically-distinct human blood neutrophil populations differentially correlated with melanoma stage. 826644-.


Coen, Oliver, Corrie, Pippa, Marshall, Helen, Plummer, Ruth, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Hook, Jane, Bell, Sue, Sagoo, Gurdeep S, Meads, David, Bestall, Janine
et al (show 10 more authors) (2021) The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma. BMC CANCER, 21 (1). 761-.


Au, Lewis, Hatipoglu, Emine, Robert de Massy, Marc, Litchfield, Kevin, Beattie, Gordon, Rowan, Andrew, Schnidrig, Desiree, Thompson, Rachael, Byrne, Fiona, Horswell, Stuart
et al (show 195 more authors) (2021) Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer Cell, 39 (11). 1497-1518.e11.


McCarthy, Caroline, Fedele, Stefano, Ottensmeier, Christian ORCID: 0000-0003-3619-1657 and Shaw, Richard J ORCID: 0000-0002-5157-4042
(2021) Early-Phase Interventional Trials in Oral Cancer Prevention. CANCERS, 13 (15). 3845-.


Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles ORCID: 0000-0003-3638-3202, McKenzie, Hayley
et al (show 7 more authors) (2023) The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24 (2). 1746-.


Banna, Giuseppe L, Cantale, Ornella, Muthuramalingam, Sethupathi, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Signori, Alessio, McKenzie, Hayley, Escriu, Carles ORCID: 0000-0003-3638-3202
et al (show 7 more authors) (2022) Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study. INTERNATIONAL IMMUNOPHARMACOLOGY, 110. 108985-.


Arriola, Edurne, Wheater, Matthew, Lopez, Maria Antonette, Thomas, Gareth and Ottensmeier, Christian ORCID: 0000-0003-3619-1657
(2016) Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis. ONCOIMMUNOLOGY, 5 (9). e1209615-.


Meyer, Melissa A, Dinh, Huy Q, Alimadadi, Ahmad, Araujo, Daniel J, Chatterjee, Nandini, Gutierrez, Norma A, Zhu, Yanfang Peipei, Hunter, Emma L, Liang, Shu, Seumois, Gregory
et al (show 5 more authors) (2023) Human CD79b<sup>+</sup> neutrophils in the blood are associated with early-stage melanoma. Frontiers in immunology, 14. 1224045-.


Shraibman, Bracha, Barnea, Eilon, Kadosh, Dganit Melamed, Haimovich, Yael, Slobodin, Gleb, Rosner, Itzhak, Lopez-Larrea, Carlos, Hilf, Norbert, Kuttruff, Sabrina, Song, Colette
et al (show 27 more authors) (2019) Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. (Retraction of Vol 17, Pg 2132, 2018). MOLECULAR & CELLULAR PROTEOMICS, 18 (6). p. 1270.


Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Eschweiler, Simon, Suastegui, Ciro Ramirez, King, Emma, Chudley, Lindsey, Thomas, Jaya, Oliver, Wood, Jeffrey, Danielle, McCann, Katy, Simon, Hayley
et al (show 28 more authors) (2021) Immunomodulatory effects of PI3Kδ inhibition in solid tumors – evaluation in a randomized phase II trial. [Preprint]


Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles ORCID: 0000-0003-3638-3202, McKenzie, Hayley
et al (show 9 more authors) (2023) Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis. FRONTIERS IN ONCOLOGY, 13. 1163768-.


Padgett, Lindsey, Dinh, Huy, Chee, Serena, Olingy, Claire, Wu, Runpei, Araujo, Daniel, Vijayanand, Pandurangan, Ottensmeier, Christian ORCID: 0000-0003-3619-1657 and Hedrick, Catherine
(2020) Interplay of Monocytes and T Lymphocytes in COVID-19 Severity. Science Immunology. 2020.07.17.209304-.


Fennell, Dean A, Ewings, Sean, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Califano, Raffaele, Hanna, Gerard G, Hill, Kayleigh, Danson, Sarah, Steele, Nicola, Nye, Mavis, Johnson, Lucy
et al (show 11 more authors) (2021) Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. LANCET ONCOLOGY, 22 (11). pp. 1530-1540.


Arriola, Edurne, Wheater, Matthew, Galea, Ian, Cross, Nadia, Maishman, Tom, Hamid, Debbie, Stanton, Louise, Cave, Judith, Geldart, Tom, Mulatero, Clive
et al (show 6 more authors) (2016) Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC. JOURNAL OF THORACIC ONCOLOGY, 11 (9). pp. 1511-1521.


Jones, Robert P ORCID: 0000-0001-5608-001X, Mielgo, Ainhoa, Schmid, Michael ORCID: 0000-0002-3445-0013, Bury, Danielle, Andrews, Timothy, Burdak-Rothkamm, Susanne ORCID: 0000-0002-3840-2844, Shackcloth, Michael, J. S. Cross, Timothy, Fenwick, Stephen, Malik, Hassan Z
et al (show 4 more authors) (2023) PINCER (A Platform Study for solId orgaN CancERs): an agile pan-network platform study to deliver high-quality translational research. BRITISH JOURNAL OF SURGERY, 110 (9). pp. 1108-1111.


Middleton, Gary, Brock, Kristian, Savage, Joshua, Mant, Rhys, Summers, Yvonne, Connibear, John, Shah, Riyaz, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Shaw, Paul, Lee, Siow-Ming
et al (show 4 more authors) (2020) Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial. The Lancet Respiratory Medicine, 8 (9). pp. 895-904.


Vimalachandran, Dale ORCID: 0000-0001-5817-8969, Jones, Robert P ORCID: 0000-0001-5608-001X, Dickson, Ed, Seehra, Jaspreet, Acheson, Austin, Griffiths, Ewen A, Kamarajah, Sivesh, Leung, Elaine, Torrance, Andrew, Ottensmeier, Christian ORCID: 0000-0003-3619-1657
et al (show 9 more authors) (2023) SARS-CoV-2 in the abdomen or pelvis: SAFE SURGERY study. BRITISH JOURNAL OF SURGERY, 110 (3). pp. 306-309.


Hanley, Christopher Jon, Waise, Sara, Rachel, Parker, Lopez, Maria-Antoinette, Taylor, Julian, Kimbley, Lucy, West, Jonathon, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Rose-Zerilli, Mat and Thomas, Gareth
(2020) Spatially discrete signalling niches regulate fibroblast heterogeneity in human lung cancer. CANCER RESEARCH, 80 (21). 2020.06.08.134270-.


McCann, Katy, von Witzleben, Adrian, Thomas, Jaya, Wang, Chuan, Wood, Oliver, Singh, Divya, Boukas, Konstantinos, Bendjama, Kaidre, Silvestre, Nathalie, Nielsen, Finn Cilius
et al (show 8 more authors) (2022) Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer. Journal for immunotherapy of cancer, 10 (3). e003821-.


Danson, Sarah, Plummer, Ruth, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Hook, Jane, Marshall, Helen, Sagoo, Gurdeep, Meads, David, Bestall, Janine, Velikova, Galina, Gallagher, Ferdia
et al (show 6 more authors) (2019) A randomised phase III multicentre trial to evaluate the duration of anti-PD1 monoclonal antibody monotherapy in patients with metastatic melanoma (DANTE) - Stage 1 Results. .

This list was generated on Sat Mar 16 15:38:13 2024 GMT.